New implant aims to protect insulin cells in diabetes patients
NCT ID NCT06408311
First seen Mar 28, 2026 · Last updated May 13, 2026 · Updated 8 times
Summary
This early-stage study tests whether a device called ENC-201-CED can safely hold insulin-producing cells under the skin in people with type 1 diabetes. Ten participants who already qualify for standard islet transplants will receive the device. The main goal is to check for side effects, not to cure diabetes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS TYPE 1 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
McGill University Health Centre
Montreal, Quebec, H4A 3J1, Canada
-
UHN
Toronto, Ontario, M5G 2C4, Canada
Conditions
Explore the condition pages connected to this study.